Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

3.4%

1 terminated out of 29 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

45%

13 trials in Phase 3/4

Results Transparency

10%

2 of 20 completed with results

Key Signals

2 with results95% success

Data Visualizations

Phase Distribution

27Total
Not Applicable (5)
P 1 (3)
P 2 (6)
P 3 (7)
P 4 (6)

Trial Status

Completed20
Unknown7
Recruiting1
Terminated1

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (29)

Showing 20 of 20 trials
NCT07316504Not ApplicableRecruiting

Optimal Strategy to Correct Stent underexpAnsion in Resistant Lesions

NCT02039739CompletedPrimary

Orsiro™ Drug Eluting Stent in Routine Clinical Practice

NCT02039713TerminatedPrimary

DESyne in Routine Clinical Practice

NCT01004575Not ApplicableCompleted

Safety and Efficacy Study of Kaname Coronary Stent System for the Treatment of Patients With Coronary Artery Disease

NCT00979758Phase 2Completed

Strengthening Transplantation Effects of Bone Marrow Mononuclear Cells With Atorvastatin in Myocardial Infarction

NCT03047772Phase 2Unknown

Transplantation Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin in AMI Patients

NCT01241903Phase 1Completed

Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions

NCT02200783Not ApplicableUnknown

Randomized Comparison of Radiological Exposure With TRIPTable® in Patients With Acute Coronary Syndromes

NCT00269893Phase 3Completed

A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty

NCT00269906Phase 3Completed

A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary Angioplasty

NCT00271401Phase 3CompletedPrimary

A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

NCT00269880Phase 3CompletedPrimary

A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.

NCT01179126Phase 3Unknown

Strategies of Revascularization in Patients With ST-segment Elevation Myocardial Infarction (STEMI) and Multivessel Disease

NCT01174433Phase 1Completed

Safety Study to Assess the FEasibility of Use of the TRYTON Bifurcation Coronary Stent System (SAFE-TRY)

NCT00345631Phase 3CompletedPrimary

Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

NCT00533156Phase 2CompletedPrimary

Plug Arterial Closure System (PACS, 7F)

NCT00574691Phase 1CompletedPrimary

ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EU

NCT00398463Phase 4CompletedPrimary

Study of Tirofiban Administration in Patients With Aspirin and or Clopidogrel Resistance

NCT00610870Not ApplicableCompletedPrimary

Effect of Atorvastatin Administration Before Primary Percutaneous Coronary Intervention

NCT00390832Phase 3Completed

Efficacy Study of Erythropoietin After Revascularization in Myocardial Infarction (REVIVAL-3)

Scroll to load more

Research Network

Activity Timeline